Abstract. A common LH variant (V-LH) with Trp8Arg and Ile15Thr is often associated with ovarian dysfunction primarily in the Japanese population, and the LHB gene encoding V-LH is linked with a hyperfunctional promoter that could partly compensate for the somewhat weak biological effect of the V-LH in the Finnish and other several populations. We analyzed the promoter region in a Japanese infertile woman homozygous for the V-LH, to examine whether the hyperfunctional promoter is present or absent in the Japanese V-LH carriers with ovarian dysfunction. Direct sequencing was performed for a 661 bp promoter region from -8 to -668 bp of LHB, revealing homozygosity for eight nucleotide substitutions (-238A>G, -276G>A, -489C>A, -490T>A, -504T>A, -506T>C, -525T>G, and -552C>T) that are identical to those found in the hyperfunctional promoter. The results suggest that ovarian dysfunction frequently observed in the Japanese V-LH carriers would be due to some population-specific genetic and/or environmental factor(s) rather than to the lack of the hyperfunctional promoter and the resultant low biological effect of the V-LH. In addition, the tight linkage between the two missense substitutions in the coding region and the eight nucleotide substitutions in the promoter region of LHB appears to be common to various ethnic groups. A genetic variant of LH (V-LH) with two completely linked Trp8Arg and Ile15Thr substitutions in the LH b-subunit gene (LHB) has been identified in various populations [1,2]. This common V-LH is immunologically undetectable when a monoclonal antibody recognizing an epitope present in the intact LH a/b dimer is utilized. Trp8Arg is primarily responsible for the altered immunoreactivity, whereas Ile15Thr introduces an extra glycosylation site into the LH b chain. The V-LH has a stronger in vitro bioactivity and a shorter circulatory half-life than the wildtype LH (WT-LH), and the overall hormonal function appears to be somewhat weaker in the V-LH than in the WT-LH [1,2]. The functional difference between the V-LH and the WT-LH may predispose the V-LH carriers to ovarian disorders. Notably, association of the V-LH homozygosity with irregular menses and infertility, and that of the V-LH heterozygosity with infertility and premature ovarian failure (POF), have frequently been observed in the Japanese population [3][4][5][6], whereas such findings are absent in the Finnish population and have not clearly been demonstrated in other Caucasian populations [1,2]. In this regard, although LHB encoding V-LH is accompanied by additional eight nucleotide changes in the promoter region that enhance the promoter activity by ~40% and compensate for the bio-